Compounds > anidulafungin
Page last updated: 2024-09-05

anidulafungin and Allergic Bronchopulmonary Mycosis

anidulafungin has been researched along with Allergic Bronchopulmonary Mycosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aram, JA; Chen, X; Jin, J; Liu, Y; Lou, YJ; Meng, H; Pan, S; Patterson, TF; Schwartz, IS; Wu, D; Yan, JL; Zhang, X1
Aram, JA; Lee, DG; Lee, HJ; Lin, SS; Yan, JL1
Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W1
Al-Nakeeb, Z; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Warn, PA1
Hausott, B; Lass-Flörl, C; Ott, HW; Perkhofer, S; Sartori, B; Striessnig, B1

Trials

2 trial(s) available for anidulafungin and Allergic Bronchopulmonary Mycosis

ArticleYear
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
    BMC infectious diseases, 2019, May-28, Volume: 19, Issue:1

    Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole

2019
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.
    Mycoses, 2019, Volume: 62, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Asian People; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Placebos; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult

2019

Other Studies

3 other study(ies) available for anidulafungin and Allergic Bronchopulmonary Mycosis

ArticleYear
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole

2009
Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cell Line; Chromatography, High Pressure Liquid; Drug Interactions; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Models, Theoretical; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole

2012
Interaction of platelets and anidulafungin against Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1

    Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Blood Platelets; Cell Culture Techniques; Echinocandins; Fungal Proteins; Gene Expression; Glucosyltransferases; Humans; Hyphae; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests

2013